RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Amosy M'Koma to Inflammatory Bowel Diseases

Back to Details
This is a "connection" page, showing publications Amosy M'Koma has written about Inflammatory Bowel Diseases.
Amosy M'Koma
Connection Strength
2.456
Inflammatory Bowel Diseases
  1. Bragg MA, Breaux WA, M'Koma AE. Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational and Transformational Risks Posed by Exogenous Free Hemoglobin Alpha Chain, A By-Product of Extravasated Erythrocyte Macrophage Erythrophagocytosis. Medicina (Kaunas). 2023 07; 59(7).
    View in: PubMed
    Score: 0.816
  2. M'Koma AE. Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview. Medicina (Kaunas). 2022 Apr 21; 58(5).
    View in: PubMed
    Score: 0.751
  3. Williams AD, Korolkova OY, Sakwe AM, Geiger TM, James SD, Muldoon RL, Herline AJ, Goodwin JS, Izban MG, Washington MK, Smoot DT, Ballard BR, Gazouli M, M'Koma AE. Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease. PLoS One. 2017; 12(8):e0179710.
    View in: PubMed
    Score: 0.543
  4. M'Koma AE, Moses HL, Adunyah SE. Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences. Int J Colorectal Dis. 2011 May; 26(5):533-52.
    View in: PubMed
    Score: 0.346
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support